 







<USDEPT>DEPARTMENT OF HEALTH AND HUMAN SERVICES</USDEPT>



<USBUREAU>Food and Drug Administration</USBUREAU>


Advisory Committees; Renewals




<AGENCY>
AGENCY: 

 Food and Drug Administration, HHS.


</AGENCY>
<ACTION>
ACTION: 

 Notice.





</ACTION>
<SUMMARY>
SUMMARY: 

 The Food and Drug Administration (FDA) announces the renewal of FDA advisory committees by the Commissioner of Food
and Drugs. This notice is issued under the Federal Advisory Committee Act of October 6, 1972 (Pub. L. 92463 (5
U.S.C. app. 2)).



</SUMMARY>
<DATE>
DATES: 

 Authority for these committees will expire on the dates indicated below unless the Commissioner formally determines
that renewal is in the public interest.




<TABLE>



1Name of the Committee

1Date of Expiration


Anesthetic and Life Support Drugs Advisory Committee

May 1, 1996

Blood Products Advisory Committee 

May 13, 1996
Pulmonary-Allergy Drugs Advisory Committee

May 30, 1996
Drug Abuse Advisory Committee

May 31, 1996
Science Advisory Board to the National Center
 for Toxicological Research

June 2, 1996
Peripheral and Central Nervous System Drugs
 Advisory Committee

June 4, 1996
Psychopharmacologic Drugs Advisory Committee

June 4, 1996
Science Board to the Food and Drug 
 Administration

June 26, 1996

</TABLE>



</DATE>
<FURTHER>
FOR FURTHER INFORMATION CONTACT: 

Donna M. Combs, Committee Management Office (HFA306), Food and Drug Administration, 5600 Fishers Lane, Rockville,
MD 20857, 3014432765.





Dated: August 1, 1994.

</FURTHER>
<SIGNER>
 Linda A. Suydam,

</SIGNER>
<SIGNJOB>
 Interim Deputy Commissioner for Operations.

</SIGNJOB>
<FRFILING>
[FR Doc. 9419095 Filed 8494; 8:45 am]

</FRFILING>
<BILLING>
BILLING CODE 416001F
</BILLING>

